The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
July 10th 2025
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, discusses how oncology pharmacists can lead value-based care efforts under the Enhanced Oncology Model (EOM) by improving care coordination, managing costs, aligning with performance metrics, and leveraging clinical data systems to enhance patient outcomes.
Fast Track Designation Granted to Drug for KRAS-Mutated Metastatic Colorectal Cancer
May 28th 2020FDA has granted Fast Track designation to Cardiff Oncology’s onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.
Read More
Early Screening Is Key in Colorectal Cancer
New treatments with biological agents and vaccines are creating a pathway for patients with metastatic CRC.
Read More
FDA Approves Atezolizumab as First-Line Monotherapy for Metastatic Non-Small Lung Cancer
May 19th 2020The approval is based on an interim analysis from the phase 3 IMpower110 study, which showed atezolizumab monotherapy improved overall survival by 7.1 months compared with chemotherapy in people with high PD-L1 expression, according to a press release.
Read More
Metastatic Triple-negative Breast Cancer Drug Trodelvy Available at Biologics by McKesson
May 11th 2020Sacituzumab govitecan-hziy, approved by the FDA on April 22, 2020, is the first in its class to treat metastatic, triple-negative breast cancer in patients who have received at least 2 prior therapies for metastatic disease.
Read More